Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adolfo Ferrando

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Cell|June 25, 2013
The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stabilityBryan King, Thomas Trimarchi, Linsey Reavie, et al.
Cancer Cell|August 18, 2012
Therapeutic effect of γ-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERKAntonio Maraver, Pablo J Fernández-Marcos, Daniel Herranz, et al.
Cancer Cell|April 21, 2012
Targeting nonclassical oncogenes for therapy in T-ALLPrem S Subramaniam, Dosh W Whye, Evgeni Efimenko, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic LeukemiaManuel Torres-Diz, Clara Reglero, Catherine D Falkenstein, et al.
Nature Medicine|December 23, 2008
Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemiaPedro J Real, Valeria Tosello, Teresa Palomero, et al.
Nature Immunology|January 19, 2010
Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complexLinsey Reavie, Giusy Della Gatta, Kelly Crusio, et al.
Cancer Research|August 2, 2024
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic LeukemiaManuel Torres-Diz, Clara Reglero, Catherine D Falkenstein, et al.
Nature Medicine|February 5, 2013
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALLGannie Tzoneva, Arianne Perez-Garcia, Zachary Carpenter, et al.
Nature Cell Biology|March 2, 2010
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemiaKonstantinos J Mavrakis, Andrew L Wolfe, Elisa Oricchio, et al.
Cell Reports|March 12, 2020
Detection of Marker-Free Precision Genome Editing and Genetic Variation through the Capture of Genomic SignaturesPierre Billon, Tarun S Nambiar, Samuel B Hayward, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cell|June 25, 2013
The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stabilityBryan King, Thomas Trimarchi, Linsey Reavie, et al.
Cancer Cell|August 18, 2012
Therapeutic effect of γ-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERKAntonio Maraver, Pablo J Fernández-Marcos, Daniel Herranz, et al.
Cancer Cell|April 21, 2012
Targeting nonclassical oncogenes for therapy in T-ALLPrem S Subramaniam, Dosh W Whye, Evgeni Efimenko, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic LeukemiaManuel Torres-Diz, Clara Reglero, Catherine D Falkenstein, et al.
Nature Medicine|December 23, 2008
Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemiaPedro J Real, Valeria Tosello, Teresa Palomero, et al.
Nature Immunology|January 19, 2010
Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complexLinsey Reavie, Giusy Della Gatta, Kelly Crusio, et al.
Cancer Research|August 2, 2024
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic LeukemiaManuel Torres-Diz, Clara Reglero, Catherine D Falkenstein, et al.
Nature Medicine|February 5, 2013
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALLGannie Tzoneva, Arianne Perez-Garcia, Zachary Carpenter, et al.
Nature Cell Biology|March 2, 2010
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemiaKonstantinos J Mavrakis, Andrew L Wolfe, Elisa Oricchio, et al.
Cell Reports|March 12, 2020
Detection of Marker-Free Precision Genome Editing and Genetic Variation through the Capture of Genomic SignaturesPierre Billon, Tarun S Nambiar, Samuel B Hayward, et al.
Pageof 5